| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfcc648a89841a2050127d371fe5e839 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2014-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd2b27d6facd7723248dd71e4422d900
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b3cb8a4d089ef436eca4180c0ddc940
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c62735ea89676d7ff2228f99a7fa280
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73b103deb203b2de036c4478fc8449fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60a50d881119fc68d343a8156520d061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_085a51b0a15a17acce5efe527242cff1 |
| publicationDate |
2020-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2721690-C2 |
| titleOfInvention |
Methods for identifying and predicting risk of cardiovascular event or disease or fatal outcome, methods for assessing severity and monitoring of cardiovascular event or disease, method for monitoring effectiveness of therapy |
| abstract |
FIELD: medicine. n SUBSTANCE: method for predicting the risk of myocardial infarction or fatal outcome in a subject following myocardial infarction involves measuring the expression level of a soluble trigger receptor (sTREM-1) in a sample from a subject, wherein a higher expression level of sTREM-1 relative to the reference value is a risk indicator of myocardial infarction or fatal outcome in a subject following myocardial infarction, where control value is at least 100 pg/ml. n EFFECT: present invention relates to a method for predicting the risk of myocardial infarction or fatal outcome in a subject following myocardial infarction, as well as monitoring the clinical effectiveness in myocardial infarction. n 9 cl, 5 tbl, 1 ex, 4 dwg |
| priorityDate |
2013-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |